Kazuto Nishio


Ontology type: schema:Person     


Person Info

NAME

Kazuto

SURNAME

Nishio

Publications in SciGraph latest 50 shown

  • 2022-10-05 Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer in SCIENTIFIC REPORTS
  • 2022-04-26 Performance of Idylla™RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2022-01-27 Precision cancer genome testing needs proficiency testing involving all stakeholders in SCIENTIFIC REPORTS
  • 2022-01-01 Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period in HEPATOLOGY INTERNATIONAL
  • 2021-09-22 Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial in MEDICAL ONCOLOGY
  • 2021-06-25 Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma in MODERN PATHOLOGY
  • 2021-06-11 CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M–positive lung cancer after osimertinib in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2021-02-14 PDZK1 induces resistance to apoptosis in esophageal adenocarcinoma cells in ESOPHAGUS
  • 2020-12-10 Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts in BRITISH JOURNAL OF CANCER
  • 2020-11-29 Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1) in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2020-11-05 Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis in SCIENTIFIC REPORTS
  • 2020-07-29 Molecular biomarker identification for esophageal adenocarcinoma using endoscopic brushing and magnified endoscopy in ESOPHAGUS
  • 2020-07-08 Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2020-01-20 Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib in SCIENTIFIC REPORTS
  • 2019-12-20 Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors in SCIENTIFIC REPORTS
  • 2019-09-30 Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI in ONCOGENESIS
  • 2019-09-13 Clinical and immune profiling for cancer of unknown primary site in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-08-05 A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing in SCIENTIFIC REPORTS
  • 2019-07-18 Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing in SCIENTIFIC REPORTS
  • 2018-10-09 An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC in ONCOGENE
  • 2018-08-16 Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study in BMC CANCER
  • 2018-05 Genital mucosal melanoma with somatic SF3B1 R625C mutation in EUROPEAN JOURNAL OF DERMATOLOGY
  • 2018-04-26 HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer in BREAST CANCER
  • 2017-10-06 Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study) in BMC CANCER
  • 2017-08-22 Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation in DIAGNOSTIC PATHOLOGY
  • 2017-08-05 Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-04-19 Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A in BMC CANCER
  • 2017-03-06 Expectation of a Decrease in Pain Affects the Prognosis of Pain in Cancer Patients: a Prospective Cohort Study of Response to Morphine in INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE
  • 2016-11-04 Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients in SCIENTIFIC REPORTS
  • 2016-04-06 Characterization of the cytotoxic activity of [2]rotaxane (TRO-A0001), a novel supramolecular compound, in cancer cells in ARCHIVES OF PHARMACAL RESEARCH
  • 2016-02-09 Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget’s disease in INVESTIGATIONAL NEW DRUGS
  • 2015-09-24 Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer in SCIENTIFIC REPORTS
  • 2015-05-11 Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib in ONCOGENE
  • 2015-05-08 Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2015-02-05 A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer in BRITISH JOURNAL OF CANCER
  • 2015-01-05 Performance of a novel KRAS mutation assay for formalin-fixed paraffin embedded tissues of colorectal cancer in SPRINGERPLUS
  • 2014-09-09 Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-09-05 Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer in GASTRIC CANCER
  • 2014-08-08 Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines in SPRINGERPLUS
  • 2014-07-21 Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib in BMC CANCER
  • 2014-05-27 Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer in MOLECULAR CANCER
  • 2013-12-23 The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer in ONCOGENE
  • 2013-09-18 A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-07-16 Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer in BRITISH JOURNAL OF CANCER
  • 2012-01-12 FGFR2 gene amplification and clinicopathological features in gastric cancer in BRITISH JOURNAL OF CANCER
  • 2012-01-12 Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells in BRITISH JOURNAL OF CANCER
  • 2011-11-10 Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4) in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2011-09-13 Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors in INVESTIGATIONAL NEW DRUGS
  • 2011-09-06 Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer in BRITISH JOURNAL OF CANCER
  • 2011-07-05 Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.258622.9", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413967.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415740.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9707.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.258799.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.440895.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.251924.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26999.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411217.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416948.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.486756.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410914.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.460141.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414830.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26790.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415479.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412002.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419828.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.459839.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.420061.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410781.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476017.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412857.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.497282.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26091.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.272242.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4444.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415766.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.473495.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417233.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415492.f", 
            "type": "Organization"
          }
        ], 
        "familyName": "Nishio", 
        "givenName": "Kazuto", 
        "id": "sg:person.01062765675.36", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-8275-0846"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062765675.36", 
          "https://orcid.org/0000-0002-8275-0846"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-11-24T21:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/person/person_961.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01062765675.36'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01062765675.36'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01062765675.36'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01062765675.36'


     

    This table displays all metadata directly associated to this object as RDF triples.

    85 TRIPLES      11 PREDICATES      45 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01062765675.36 schema:affiliation N87a0a0bb5ed240118f623b77ea1ae3b9
    2 grid-institutes:grid.251924.9
    3 grid-institutes:grid.258799.8
    4 grid-institutes:grid.26091.3c
    5 grid-institutes:grid.26790.3a
    6 grid-institutes:grid.26999.3d
    7 grid-institutes:grid.272242.3
    8 grid-institutes:grid.410781.b
    9 grid-institutes:grid.410914.9
    10 grid-institutes:grid.411217.0
    11 grid-institutes:grid.412002.5
    12 grid-institutes:grid.412857.d
    13 grid-institutes:grid.413967.e
    14 grid-institutes:grid.414830.a
    15 grid-institutes:grid.415479.a
    16 grid-institutes:grid.415492.f
    17 grid-institutes:grid.415740.3
    18 grid-institutes:grid.415766.7
    19 grid-institutes:grid.416948.6
    20 grid-institutes:grid.417233.0
    21 grid-institutes:grid.419828.e
    22 grid-institutes:grid.420061.1
    23 grid-institutes:grid.440895.4
    24 grid-institutes:grid.4444.0
    25 grid-institutes:grid.459839.a
    26 grid-institutes:grid.460141.6
    27 grid-institutes:grid.473495.8
    28 grid-institutes:grid.476017.3
    29 grid-institutes:grid.486756.e
    30 grid-institutes:grid.497282.2
    31 grid-institutes:grid.51462.34
    32 grid-institutes:grid.65499.37
    33 grid-institutes:grid.9707.9
    34 schema:familyName Nishio
    35 schema:givenName Kazuto
    36 schema:identifier N2b8fe67367a04411924fba234118166a
    37 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062765675.36
    38 https://orcid.org/0000-0002-8275-0846
    39 schema:sdDatePublished 2022-11-24T21:37
    40 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    41 schema:sdPublisher N1e6605a54acc449292835eb46297098f
    42 sgo:license sg:explorer/license/
    43 sgo:sdDataset persons
    44 rdf:type schema:Person
    45 N1e6605a54acc449292835eb46297098f schema:name Springer Nature - SN SciGraph project
    46 rdf:type schema:Organization
    47 N2b8fe67367a04411924fba234118166a schema:name orcid_id
    48 schema:value 0000-0002-8275-0846
    49 rdf:type schema:PropertyValue
    50 N87a0a0bb5ed240118f623b77ea1ae3b9 schema:affiliation grid-institutes:grid.258622.9
    51 sgo:isCurrent true
    52 rdf:type schema:OrganizationRole
    53 grid-institutes:grid.251924.9 schema:Organization
    54 grid-institutes:grid.258622.9 schema:Organization
    55 grid-institutes:grid.258799.8 schema:Organization
    56 grid-institutes:grid.26091.3c schema:Organization
    57 grid-institutes:grid.26790.3a schema:Organization
    58 grid-institutes:grid.26999.3d schema:Organization
    59 grid-institutes:grid.272242.3 schema:Organization
    60 grid-institutes:grid.410781.b schema:Organization
    61 grid-institutes:grid.410914.9 schema:Organization
    62 grid-institutes:grid.411217.0 schema:Organization
    63 grid-institutes:grid.412002.5 schema:Organization
    64 grid-institutes:grid.412857.d schema:Organization
    65 grid-institutes:grid.413967.e schema:Organization
    66 grid-institutes:grid.414830.a schema:Organization
    67 grid-institutes:grid.415479.a schema:Organization
    68 grid-institutes:grid.415492.f schema:Organization
    69 grid-institutes:grid.415740.3 schema:Organization
    70 grid-institutes:grid.415766.7 schema:Organization
    71 grid-institutes:grid.416948.6 schema:Organization
    72 grid-institutes:grid.417233.0 schema:Organization
    73 grid-institutes:grid.419828.e schema:Organization
    74 grid-institutes:grid.420061.1 schema:Organization
    75 grid-institutes:grid.440895.4 schema:Organization
    76 grid-institutes:grid.4444.0 schema:Organization
    77 grid-institutes:grid.459839.a schema:Organization
    78 grid-institutes:grid.460141.6 schema:Organization
    79 grid-institutes:grid.473495.8 schema:Organization
    80 grid-institutes:grid.476017.3 schema:Organization
    81 grid-institutes:grid.486756.e schema:Organization
    82 grid-institutes:grid.497282.2 schema:Organization
    83 grid-institutes:grid.51462.34 schema:Organization
    84 grid-institutes:grid.65499.37 schema:Organization
    85 grid-institutes:grid.9707.9 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...